WWB
Windward Bio Group AG · NASDAQ
- Market cap
- $1.35B
- Shares out
- 59.6M
Windward Bio Group AG (WWB) is a Biotechnology: Biological Products (No Diagnostic Substances) company listed on NASDAQ. In the last 30 days Quantisnow tracked 14 wire items for WWB, including 12 insider trades, 1 SEC filing and 1 press release or news item. The most recent was published Nov 18, 2026.
News · 26 weeks14+100%
2026-05-242026-11-15
Mix1490d
- Insider12(86%)
- SEC Filings1(7%)
- Other1(7%)
Activity · 52 weeks143 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
14 items- INSIDERDirector David P Bonita bought $20,000,007 worth of shares (1,176,471 units at $17.00), converted options into 5,172,944 shares, exercised 216,668 shares at a strike of $0.02 and covered exercise/tax liability with 232 shares (SEC Form 4)4 - WINDWARD BIO GROUP AG (0002145089) (Issuer)
- INSIDERDirector Orbimed Advisors Llc bought $20,000,007 worth of shares (1,176,471 units at $17.00), converted options into 5,172,944 shares, exercised 216,668 shares at a strike of $0.02 and covered exercise/tax liability with 232 shares (SEC Form 4)4 - WINDWARD BIO GROUP AG (0002145089) (Issuer)
- INSIDERDirector Otello Stampacchia bought $29,750,000 worth of shares (1,750,000 units at $17.00) and converted options into 3,588,520 shares (SEC Form 4)4 - WINDWARD BIO GROUP AG (0002145089) (Issuer)
- PRWindward Bio to Participate at the Jefferies London Global Healthcare ConferenceBASEL, Switzerland, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Windward Bio Group AG ("Windward") (NASDAQ:WWB), a clinical-stage biotechnology company developing ultra-long-acting antibody medicines for patients with serious respiratory and dermatologic diseases, today announced that members of management will present at the Jefferies London Global Healthcare Conference on Wednesday, November 18, 2026, at 8:30 a.m.GMT. A live and archived webcast of the fireside chat will be available via the News & Events page in the Investors section of the Windward Bio website. About Windward Bio Group AG Windward (NASDAQ:WWB) is a global, clinical-stage biotechnology company developing ultra-long-acting anti
- INSIDERDirector Mufti Iqbal Rasool was granted 22,675 share options (SEC Form 4)4 - Mufti Iqbal Rasool (CIK 0002163328)
- INSIDERChief Operating Officer Harris Kevin Andrew was granted 33,206 shares, increasing direct ownership by 4% to 960,966 units (SEC Form 4)4 - Harris Kevin Andrew (CIK 0002157619)
- INSIDERChief Executive Officer Santarelli Luca was granted 815,755 employee share options (SEC Form 4)4 - Santarelli Luca (CIK 0002162137)
- INSIDERChief Financial Officer D'Augusta Claudia was granted 180,160 employee share options (SEC Form 4)4 - D'Augusta Claudia (CIK 0002160088)
- INSIDERDirector Bonita David P was granted 22,675 stock options (SEC Form 4)4 - Bonita David P (CIK 0001572451)
- INSIDERDirector Stampacchia Otello was granted 22,675 share options (SEC Form 4)4 - Stampacchia Otello (CIK 0001361712)
- INSIDERDirector Kapadia Sandip was granted 100,000 shares (SEC Form 4)4 - Kapadia Sandip (CIK 0001677141)
- INSIDERChief Medical Officer Khwaja Omar was granted 219,030 employee share options (SEC Form 4)4 - Khwaja Omar (CIK 0001776393)
- INSIDERChief Legal & Corp Dev Officer Applebaum Scott was granted 33,206 shares, increasing direct ownership by 4% to 960,966 units (SEC Form 4)4 - Applebaum Scott (CIK 0001618945)
- SECSEC Form 6-K filed by Windward Bio Group AG6-K - WINDWARD BIO GROUP AG (WWB) (CIK 0002145089)
WWB FAQ
7 questionsWhat does Windward Bio Group AG do?
Windward Bio Group is a clinical-stage biotechnology company developing ultra-long-acting antibody medicines for patients with serious respiratory and dermatologic diseases, including asthma, chronic obstructive pulmonary disease, or COPD, and atopic dermatitis. Our product candidates, WIN378 and WIN027, target clinically validated disease pathways and are engineered to remain in the body for extended periods of time, enabling less frequent dosing than currently available treatments. This design feature is combined with additional properties including enhanced target affinity, dual target...What is the latest news on WWB?
In the last 30 days Quantisnow tracked 14 wire items for WWB: 12 insider trades, 1 SEC filing and 1 press release or news item. The most recent was published on November 18, 2026.Where does WWB stock trade?
Windward Bio Group AG (WWB) is listed on NASDAQ.What sector and industry is WWB in?
Windward Bio Group AG operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did Windward Bio Group AG go public?
Windward Bio Group AG (WWB) completed its IPO in 2026.What companies are similar to WWB?
Notable peers in the same industry include BIIB (Biogen Inc.), MRNA (Moderna Inc.), GILD (Gilead Sciences Inc.), RVMD (Revolution Medicines Inc.), AMGN (Amgen Inc.). Compare WWB side-by-side with any of them on Quantisnow.How can I track WWB on Quantisnow?
Quantisnow aggregates Windward Bio Group AG's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow WWB to receive live email and push alerts on every new disclosure.
Is something on this page wrong, or out of date? Request a change